» Articles » PMID: 11434427

Molecular Virology of Hepatitis C Virus

Overview
Specialty General Medicine
Date 2001 Jul 4
PMID 11434427
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV), discovered in 1989, is the major causative agent of parenteral non-A, non-B hepatitis worldwide. Following the development of a method of diagnosing HCV infection, it became apparent that HCV frequently causes chronic hepatitis. Persistent infection with HCV is implicated in liver cirrhosis and hepatocellular carcinoma. Current worldwide estimations suggest that more than 170 million people have been infected with HCV, an enveloped positive single-stranded RNA (9.6-kilobases) virus belonging to the Flaviviridae. The HCV genome shows remarkable sequence variation, especially in the hypervariable region 1 of the E2 protein-encoding region, and globally, HCV appears to be distributed with more than 30 genotypes. Complicated "quasispecies" and frequent mutations of viral genomes have also emerged. The HCV genome encodes a large polyprotein precursor of about 3,000 amino acid residues, and this precursor protein is cleaved by the host and viral proteinases to generate at least 10 proteins in the following order: NH2-core-envelope (E1)-E2-p7-nonstructural protein 2 (NS2)-NS3-NS4A-NS4B-NS5A-NS5B-COOH. These viral proteins not only function in viral replication but also affect a variety of cellular functions. Although several explanations have been proposed, the mechanisms of HCV infection and replication in targeted cells, the mechanism of persistent viral infection, and the pathogenesis of hepatic diseases (hepatitis or hepatocellular carcinoma) are all poorly understood. A major reason why these mechanisms remain unclear is the lack of a good experimental HCV replication system. Although several classical trials using cultured cells have been reported, several new, more promising experimental strategies (generations of infectious cDNA clone, replicon, animal models, etc.) are currently being designed and tested, in order to resolve these problems. In addition, new therapies for chronic hepatitis have also been developed. The enormous body of information collected thus far in the field of HCV research is summarized below, and an overview of the current status of HCV molecular virology of HCV is provided.

Citing Articles

Knowledge, attitude, and practices towards hepatitis infection and its associated factors among adults in Gondar town, northwest Ethiopia; a community-based study, 2021.

Angelo A, Teketelew B, Berta D, Chane E, Cherie N, Nigus M J Health Popul Nutr. 2024; 43(1):178.

PMID: 39497180 PMC: 11536916. DOI: 10.1186/s41043-024-00654-9.


P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis.

Manzoor S, Khalid M, Idrees M PLoS One. 2022; 17(5):e0259727.

PMID: 35594248 PMC: 9122194. DOI: 10.1371/journal.pone.0259727.


Discovery of Hepatitis C Virus: 2020 Nobel Prize in Medicine.

Laugi H Euroasian J Hepatogastroenterol. 2021; 10(2):105-108.

PMID: 33511075 PMC: 7801885. DOI: 10.5005/jp-journals-10018-1326.


Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?.

Lapa D, Garbuglia A, Capobianchi M, Del Porto P Cells. 2019; 8(4).

PMID: 30987134 PMC: 6523096. DOI: 10.3390/cells8040305.


Molecular characterization and clinical epidemiology of HCV in District Dir (Lower), Pakistan.

Ullah S, Khan M, Rahman S, Khan I, Akbar F, Babbar A Virusdisease. 2018; 29(3):369-374.

PMID: 30159373 PMC: 6111948. DOI: 10.1007/s13337-018-0457-1.